Dialog Medical, a subsidiary of Standard Register (NYSE:SR), reported today that its iMedConsent application has achieved 2011 Edition EHR Modular* Inpatient ONC-ACB Certification, which designates that the software is capable of supporting providers with Stage 1 meaningful use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA). The iMedConsent application was certified on January 31, 2013 under ICSA Labs’ ONC-ACB Electronic Health Record program and is compliant in accordance with the criteria adopted by the Secretary of Health and Human Services.
“Securing ONC-ACB Certification demonstrates a commitment to supporting hospitals’ meaningful use initiatives,” said Tim Kelly, vice president of marketing for Dialog Medical. “Certification in five inpatient domain criteria is essential to the attestation needs of our current and prospective clients.”
“Standard Register Healthcare is committed to advancing the patient engagement strategies of hospitals and providers,” said John King, president of Standard Register Healthcare. “Receipt of ONC-ACB Certification of the iMedConsent application punctuates our commitment to supporting patient-centered communications in hospitals seeking funding for their EHR investment under the ARRA.”
ICSA Labs, an independent division of Verizon, offers vendor-neutral testing and certification. Its electronic health record certification and testing program provides verification that the certified EHR technology supports meaningful use, as well as helps health care organizations protect sensitive and private patient information.
iMedConsent application version 3.833 meets the following certification criteria:
- 170.302(g) Smoking Status
- 170.302(m) Patient Specific Education Resources
- 170.306(b) Record Demographics
- 170.306(e) Electronic Copy of Discharge Instructions
- 170.306(h) Advance Directives
- 170.302(o) Access Control
- 170.302(p) Emergency Access
- 170.302(q) Automatic Log-off
- 170.302(r) Audit Log
- 170.302(s) Integrity
- 170.302(t) Authentication
- 170.302(u) General Encryption
- 170.302(v) Encryption When Exchanging Electronic Health Information
The additional software relied upon to comply with one or more of the certification criteria included Microsoft SQL Server 2008.
The iMedConsent application will be showcased by Standard Register Healthcare and Dialog Medical at the HIMSS13 Annual Conference and Exhibition in booth 1117.
About Dialog Medical
Dialog Medical, a Standard Register Healthcare company, is the leading provider of patient engagement solutions including tools for supporting the informed consent process as well as the provision of pre- and post-procedure instructions and patient education materials. The company’s iMedConsent™ application is currently used by more than 15,000 physicians and in more than 200 hospitals nationwide. More information on Dialog Medical and its products is available at www.dialogmedical.com. For additional information on the 2011 Edition EHR Modular* Inpatient ONC-ACB Certification of the iMedConsent application version 3.833, visit www.dialogmedical.com/meaningful_use/
About Standard Register
Standard Register (NYSE:SR), celebrating 100 years of innovation, is trusted by the world’s leading companies to advance their reputations by aligning their communications with corporate standards and priorities. Providing market-specific insights and a compelling portfolio of solutions to address the changing business landscape in commercial, healthcare, financial services and industrial markets, Standard Register is the recognized leader in the management and execution of mission-critical communications. More information is available at www.standardregister.com.
Standard Register Healthcare is a business unit of Standard Register, serving more than 3,100 clients from across the healthcare delivery network, including acute, ambulatory, and long-term care, managed care and the suppliers that support them. A recognized leader in managing critical information and communications, Standard Register Healthcare, together with Dialog Medical, a subsidiary of Standard Register, provides industry-leading technology, solutions and services to accelerate performance, attract and educate patients, enhance safety and support patient-centered care. More information is available at www.standardregister.com/healthcare.
About ICSA Labs
ICSA Labs, an independent division of Verizon, offers third-party testing and certification of security and health IT products, as well as network-connected devices, to measure product compliance, reliability and performance for many of the world’s top security vendors. ICSA Labs is an ISO/IEC 17025:2005 accredited and 9001:2008 registered organization. Visit http://www.icsalabs.com and http://www.icsalabs.com/blogs for more information.
* This EHR Module is 2011 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. iMedConsent™ Application, Version 3.833 was certified on January 31, 2013. CHPL Product Number: 130003R00
Standard Register Healthcare
Christine Winters, 937-221-1804
Carol Merry, 614-383-1624
Carlos Arcila, 908-559-8031